Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Poewe

Showing results (41-50 of 602) with videos related to

Pageof 61
Sort By:
Journal of Parkinson'S Disease|March 1, 2024
Pharmacotherapy for Disease Modification in Early Parkinson's Disease: How Early Should We Be?Philipp Mahlknecht, Werner Poewe
Neurologic Clinics|November 30, 2014
Movement disorders in systemic diseasesWerner Poewe, Atbin Djamshidian-Tehrani
Brain : a Journal of Neurology|August 27, 2020
Long duration response in Parkinson's disease: levodopa revisitedWerner Poewe, Alberto J Espay
Movement Disorders Clinical Practice|October 27, 2018
Pharmacogenetics of Parkinson's Disease in Clinical PracticeJean-Christophe Corvol, Werner Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2015
Eldad Melamed 1942-2015: Ave atque--A memorialC Warren Olanow, Werner Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|August 25, 2015
PrefaceWerner Poewe, Christopher G Goetz
Neurology|June 2, 2019
Comment: Autologous mesenchymal stem cells: Hope for patients with multiple system atrophy?Florian Krismer, Werner Poewe, Klaus Seppi
European Journal of Neurology|July 25, 2023
The 20th anniversary of the first clinical use of Stalevo<sup>®</sup>Peter Jenner, Werner Poewe, Heinz Reichmann
Journal of Neural Transmission (Vienna, Austria : 1996)|September 9, 2015
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-offMikko Kuoppamäki, Mika Leinonen, Werner Poewe
The Lancet. Neurology|December 20, 2005
The diagnosis of Parkinson's diseaseEduardo Tolosa, Gregor Wenning, Werner Poewe
Pageof 61

Showing results (41-50 of 602) with videos related to

Sort By:
Pageof 61
Journal of Parkinson'S Disease|March 1, 2024
Pharmacotherapy for Disease Modification in Early Parkinson's Disease: How Early Should We Be?Philipp Mahlknecht, Werner Poewe
Neurologic Clinics|November 30, 2014
Movement disorders in systemic diseasesWerner Poewe, Atbin Djamshidian-Tehrani
Brain : a Journal of Neurology|August 27, 2020
Long duration response in Parkinson's disease: levodopa revisitedWerner Poewe, Alberto J Espay
Movement Disorders Clinical Practice|October 27, 2018
Pharmacogenetics of Parkinson's Disease in Clinical PracticeJean-Christophe Corvol, Werner Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2015
Eldad Melamed 1942-2015: Ave atque--A memorialC Warren Olanow, Werner Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|August 25, 2015
PrefaceWerner Poewe, Christopher G Goetz
Neurology|June 2, 2019
Comment: Autologous mesenchymal stem cells: Hope for patients with multiple system atrophy?Florian Krismer, Werner Poewe, Klaus Seppi
European Journal of Neurology|July 25, 2023
The 20th anniversary of the first clinical use of Stalevo<sup>®</sup>Peter Jenner, Werner Poewe, Heinz Reichmann
Journal of Neural Transmission (Vienna, Austria : 1996)|September 9, 2015
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-offMikko Kuoppamäki, Mika Leinonen, Werner Poewe
The Lancet. Neurology|December 20, 2005
The diagnosis of Parkinson's diseaseEduardo Tolosa, Gregor Wenning, Werner Poewe
Pageof 61